JOHNSON & JOHNSON

JNJNYSE· Pharmaceutical Preparations

Price History

Revenue

$94.2B

▲ 6.0% YoY

Net Income

$26.8B

▲ 90.6% YoY

EPS

$11.03

▲ 90.5% YoY

Cash

$19.7B

▼ 18.2% YoY

FY 2025 · As of 2025-12-28

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.